BioLineRx Ltd. (BLRX)
3.00
+0.19
(+6.76%)
USD |
NASDAQ |
Aug 24, 16:00
2.80
-0.20
(-6.67%)
After-Hours: 20:00
BioLineRx Max Drawdown (5Y) : 98.88% for July 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| July 31, 2026 | 98.88% |
| June 30, 2026 | 98.88% |
| May 31, 2026 | 98.88% |
| April 30, 2026 | 98.88% |
| March 31, 2026 | 98.85% |
| February 28, 2026 | 98.76% |
| January 31, 2026 | 98.76% |
| December 31, 2025 | 98.76% |
| November 30, 2025 | 98.76% |
| October 31, 2025 | 98.76% |
| September 30, 2025 | 98.76% |
| August 31, 2025 | 98.76% |
| July 31, 2025 | 98.76% |
| June 30, 2025 | 98.76% |
| May 31, 2025 | 98.76% |
| April 30, 2025 | 98.76% |
| March 31, 2025 | 98.48% |
| February 28, 2025 | 98.30% |
| January 31, 2025 | 98.18% |
| December 31, 2024 | 97.41% |
| November 30, 2024 | 97.41% |
| October 31, 2024 | 97.41% |
| September 30, 2024 | 97.41% |
| August 31, 2024 | 97.41% |
| July 31, 2024 | 97.41% |
| Date | Value |
|---|---|
| June 30, 2024 | 97.41% |
| May 31, 2024 | 97.41% |
| April 30, 2024 | 97.41% |
| March 31, 2024 | 97.41% |
| February 29, 2024 | 97.41% |
| January 31, 2024 | 97.41% |
| December 31, 2023 | 97.41% |
| November 30, 2023 | 97.41% |
| October 31, 2023 | 97.41% |
| September 30, 2023 | 97.41% |
| August 31, 2023 | 97.41% |
| July 31, 2023 | 97.41% |
| June 30, 2023 | 97.41% |
| May 31, 2023 | 97.41% |
| April 30, 2023 | 97.41% |
| March 31, 2023 | 97.41% |
| February 28, 2023 | 97.41% |
| January 31, 2023 | 97.40% |
| December 31, 2022 | 97.40% |
| November 30, 2022 | 97.24% |
| October 31, 2022 | 97.22% |
| September 30, 2022 | 97.22% |
| August 31, 2022 | 97.22% |
| July 31, 2022 | 97.22% |
| June 30, 2022 | 97.22% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| XTL Biopharmaceuticals Ltd. | 90.10% |
| Kamada Ltd. | 67.69% |
| Can-Fite BioPharma Ltd. | 99.43% |
| Galmed Pharmaceuticals Ltd. | 99.94% |
| Revium Recovery, Inc. | 98.64% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -71.29 |
| Beta (5Y) | 1.540 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 79.11% |
| Historical Sharpe Ratio (5Y) | -0.722 |
| Historical Sortino (5Y) | -1.290 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 39.54% |